Shocking statement regarding Pfizer…

 

Pfizer and BioNTech have unveiled positive results from their trial conducted on children aged 5 to 11. Their Covid-19 vaccine is "safe," elicits a "robust" immune response, and is "well-tolerated," they stated in a press release.

Those aged 12-17 have been eligible for the Covid-19 vaccine since June 15th. Currently, 69% of this age group has received a first dose. Faced with the spread of the Delta variant, a question arises: should children under 12 be vaccinated? While the benefits of the Covid-19 vaccine for younger children are still debated, Pfizer and BioNTech have just announced that their vaccine is "safe" for children aged 5 to 11.
Pfizer: a "robust" immune response and a "well-tolerated" vaccine.

Pfizer and BioNTech announced, in a press release published on September 20, the "positive results" of their trial conducted on 2,268 children aged 5 to 11. Participants received two 10-microgram doses of the vaccine, 21 days apart. As a reminder, the dose for children over 12 is 30 micrograms.